Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease
The leucine-rich repeat kinase 2 (LRRK2) G2019S mutation is a common genetic cause of Parkinson's disease (PD). Although patients with sporadic PD and individuals with LRRK2-linked PD display the classical PD phenotype, it is not known whether or not the same biological pathways are deregulated...
Main Authors: | Eugénie Mutez, Aurore Nkiliza, Karim Belarbi, Amélie de Broucker, Christel Vanbesien-Mailliot, Séverine Bleuse, Aurélie Duflot, Thomas Comptdaer, Pierre Semaille, Renaud Blervaque, David Hot, Frederic Leprêtre, Martin Figeac, Alain Destée, Marie-Christine Chartier-Harlin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-03-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996113003197 |
Similar Items
-
RNA-binding disturbances as a continuum from spinocerebellar ataxia type 2 to Parkinson disease
by: Aurore Nkiliza, et al.
Published: (2016-12-01) -
Mind the Gap: LRRK2 Phenotypes in the Clinic vs. in Patient Cells
by: Liesel Goveas, et al.
Published: (2021-04-01) -
Overexpression of Wild-Type Human Alpha-Synuclein Causes Metabolism Abnormalities in Thy1-aSYN Transgenic Mice
by: Elodie Cuvelier, et al.
Published: (2018-10-01) -
LRRK2 Phosphorylation, More Than an Epiphenomenon
by: Antoine Marchand, et al.
Published: (2020-06-01) -
The Current State-of-the Art of LRRK2-Based Biomarker Assay Development in Parkinson’s Disease
by: Hardy J. Rideout, et al.
Published: (2020-08-01)